In fact, RACK1 was not only associated with breast cancer malignancy, but its overexpression is implicated in the growth and metastasis of several other cancer types such as lung cancer, gliomas, colon cancer, prostate cancer, liver cancer, epithelial ovarian cancer, and squamous cell carcinoma of the esophagus [72]. Here, RACK1 is linked to prostate cancer.